Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Abstract Introduction Ixekizumab (IXE) is an IgG4-type monoclonal antibody targeting IL-17A indicated alone or in combination with methotrexate, for the treatment of active psoriatic arthritis (PsA) in adult patients with insufficient response or with intolerance to one or more disease-modifying ant...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Adis, Springer Healthcare
2023-07-01
|
| Seri Bilgileri: | Rheumatology and Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1007/s40744-023-00584-8 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|